Ray H. Hashemi, M.D., Ph.D. – Trademark Portfolio

Entity Type: 01

Ray H. Hashemi, M.D., Ph.D. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. The owner is based in Lancaster, CA.

Suite D

Lancaster, CA 93534

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ray H. Hashemi, M.D., Ph.D.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Ray H. Hashemi, M.D., Ph.D. have?

Ray H. Hashemi, M.D., Ph.D. has 2 U.S. trademarks filed with the USPTO.

What trademark classes does Ray H. Hashemi, M.D., Ph.D. file in?

Ray H. Hashemi, M.D., Ph.D. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What is Ray H. Hashemi, M.D., Ph.D.'s trademark registration success rate?

Ray H. Hashemi, M.D., Ph.D. has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.